GZMK and breast cancer: In all breast cancer patients (n = 1879 cases), the high expression group of GZMK (n = 935 cases) had better OS than the low expression group (n = 944 cases), with statistical significance (HR = 0.58 (0.48–0.71), P < 0.001) (Figure S3A).